Pericarditis epidemiology and demographics

Revision as of 23:39, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pericarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

HIV
Post MI
Dressler's syndrome
Post-pericardiotomy
Radiation
Tuberculosis
Uremia
Malignancy

Differentiating Pericarditis from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Pericardial Effusion
Cardiac Tamponade
Constrictive Pericarditis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Pericardiocentesis
Pericardial Window
Pericardial Stripping

Treatment Related Videos

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pericarditis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pericarditis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pericarditis epidemiology and demographics

CDC on Pericarditis epidemiology and demographics

Pericarditis epidemiology and demographics in the news

Blogs on Pericarditis epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pericarditis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. Homa Najafi, M.D.[2]

Overview

The incidence of acute pericarditis is approximately 27.7 per 100,000 individuals annually. The recurrence of disease is seen in almost 30% of patients after first episode. The mortality rate of acute pericarditis is approximately 1.1% in developed countries. Patients of all age groups may develop acute pericarditis. Although it commonly affects men in 20 to 50 years of age. Pericarditis in developed countries is most commonly due to malignancy or viral infection. It usually follows respiratory infections, most commonly echovirus or coxsackie virus. In children, it is most commonly caused by adenovirus or coxsackie virus. In developing countries pericarditis is usually secondary to tuberculosis or HIV infection. Tuberculous pericarditis, caused by Mycobacterium tuberculosis, is found in approximately 1% of all autopsied cases of TB and in 1% to 2% of instances of pulmonary TB.

Epidemiology and Demographics

Incidence

Case-fatality rate/Mortality rate

Age

Race

Gender

Developed Countries

Developing Countries

References

  1. Imazio, M; Cecchi, E; Demichelis, B; Chinaglia, A; Ierna, S; Demarie, D; Ghisio, A; Pomari, F; Belli, R; Trinchero, R (2007). "Myopericarditis versus viral or idiopathic acute pericarditis". Heart. 94 (4): 498–501. doi:10.1136/hrt.2006.104067. ISSN 1355-6037.
  2. 2.0 2.1 Kytö, Ville; Sipilä, Jussi; Rautava, Päivi (2014). "Clinical Profile and Influences on Outcomes in Patients Hospitalized for Acute Pericarditis". Circulation. 130 (18): 1601–1606. doi:10.1161/CIRCULATIONAHA.114.010376. ISSN 0009-7322.
  3. Imazio, Massimo; Bobbio, Marco; Cecchi, Enrico; Demarie, Daniela; Demichelis, Brunella; Pomari, Franco; Moratti, Mauro; Gaschino, Gianni; Giammaria, Massimo; Ghisio, Aldo; Belli, Riccardo; Trinchero, Rita (2005). "Colchicine in Addition to Conventional Therapy for Acute Pericarditis". Circulation. 112 (13): 2012–2016. doi:10.1161/CIRCULATIONAHA.105.542738. ISSN 0009-7322.
  4. Imazio, Massimo; Brucato, Antonio; Cemin, Roberto; Ferrua, Stefania; Maggiolini, Stefano; Beqaraj, Federico; Demarie, Daniela; Forno, Davide; Ferro, Silvia; Maestroni, Silvia; Belli, Riccardo; Trinchero, Rita; Spodick, David H.; Adler, Yehuda (2013). "A Randomized Trial of Colchicine for Acute Pericarditis". New England Journal of Medicine. 369 (16): 1522–1528. doi:10.1056/NEJMoa1208536. ISSN 0028-4793.
  5. Ariyarajah, Vignendra; Spodick, David H. (2007). "Acute Pericarditis". Cardiology in Review. 15 (1): 24–30. doi:10.1097/01.crd.0000210645.89717.34. ISSN 1061-5377.
  6. Troughton RW, Asher CR, Klein AL (2004). "Pericarditis". Lancet. 363 (9410): 717–27. doi:10.1016/S0140-6736(04)15648-1. PMID 15001332.
  7. Little WC, Freeman GL (2006). "Pericardial disease". Circulation. 113 (12): 1622–32. doi:10.1161/CIRCULATIONAHA.105.561514. PMID 16567581.
  8. Imazio M, Brucato A, Adler Y, Brambilla G, Artom G, Cecchi E; et al. (2007). "Prognosis of idiopathic recurrent pericarditis as determined from previously published reports". Am J Cardiol. 100 (6): 1026–8. doi:10.1016/j.amjcard.2007.04.047. PMID 17826391.
  9. Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J (1988). "Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment". J Am Coll Cardiol. 11 (4): 724–8. PMID 3351140.
  10. Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M (1999). "Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature". Am Heart J. 137 (3): 516–21. PMID 10047635.
  11. Fowler NO (1991). "Tuberculous pericarditis". JAMA. 266 (1): 99–103. PMID 2046135.
  12. Reuter H, Burgess LJ, Doubell AF (2005). "Epidemiology of pericardial effusions at a large academic hospital in South Africa". Epidemiol Infect. 133 (3): 393–9. PMC 2870262. PMID 15962545.

Template:WH Template:WS